Analysis of Jasper Therapeutics, Inc. (JSPR)
Jasper Therapeutics, Inc. is showing some interesting trends based on the recent data. Here are a few key points from the analysis:
1. **Price Movement**: The stock price has been fluctuating in the recent days, with the price closing at $17.59 on the latest available date. The price has shown some volatility, with highs around $24.98 and lows around $16.23.
2. **Technical Indicators**:
- **RSI Indicator**: The Relative Strength Index (RSI) is currently at 28.07, indicating that the stock may be oversold.
- **MACD Indicator**: The Moving Average Convergence Divergence (MACD) is negative at -0.37, but the MACD histogram is showing a slight uptrend, which could indicate a potential reversal in the short term.
- **Moving Averages**: The Simple Moving Average (SMA) is at 22.59, Exponential Moving Average (EMA) at 23.00, and Weighted Moving Average (WMA) at 22.60. These moving averages can be used to identify support and resistance levels.
3. **Relative Strength**: The RSI and MACD indicators suggest that the stock may be oversold in the short term, but traders should exercise caution as the overall trend is still bearish.
4. **Trading Volume**: It would be beneficial to analyze the trading volume along with price movements to get a better understanding of market sentiment and potential price reversals.
Overall, Jasper Therapeutics, Inc. shows some potential for a short-term reversal based on the technical indicators, but traders and investors should closely monitor the stock and consider other factors before making any trading decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were related to the Transfer Agent. The results from January 31, 2025, were reported after hours. The results from October 31, 2024, were not supplied at a specific time. The results from August 1, 2024, indicated an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin: 26.306%.
- Fiscal year ends: September 30, 2023.
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin: 30.743%.
- Most recent quarter: March 31, 2024.
- Return on assets TTM: 22.073999%.
- Return on equity TTM: 147.25%.
Stock statistics:
- Short ratio: 1.53.
- Float shares: 15,308,320,742.
- Shares short: 99,287,450.
- Average 10-day volume: 46,860,048.
- Average 90-day volume: 57,498,254.
- Shares outstanding: 15,334,099,968.
- Percent held by insiders: 5.22%.
- Percent held by institutions: 57.589%.
- Short percent of shares outstanding: 0.65%.
Valuation metrics:
- PEG ratio: 26.319502.
- Forward PE: 26.319502.
- Trailing PE: 29.59409.
- Enterprise value: $2,950,762,332,160.
- Price to book MRQ: 39.3405.
- Price to sales TTM: 7.646095.
- Enterprise to EBITDA: 22.763.
- Enterprise to revenue: 7.732.
- Market capitalization: $2,917,925,650,432.
Stock price summary:
- Beta: 1.264.
- 50-day moving average: $176.2646.
- 200-day moving average: $181.0429.
- 52-week low: $164.08.
- 52-week high: $199.62.
- 52-week change: 6.853%.
Dividends and splits:
- Payout ratio: 14.93%.
- Dividend date: May 16, 2024.
- Last split date: August 31, 2020.
- Ex-dividend date: May 10, 2024.
- Last split factor: 4-for-1 split.
- Forward annual dividend rate: $1.
- 5-year average dividend yield: 0.73%.
- Forward annual dividend yield: 0.5255%.
- Trailing annual dividend rate: $0.97.
- Trailing annual dividend yield: 0.5097%.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, suggesting efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, reflecting the company's profitability and growth.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to manage its operating expenses effectively, as seen in the stable operating income figures.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, peaking at $234,386,000,000 in 2018.
4. Total liabilities have also been on the rise, with the highest value in 2018 at $255,355,000,000.
5. Shareholders' equity has generally increased, reaching its peak at $107,147,000,000 in 2018.
6. The company has been investing more in non-current assets over the years, possibly for long-term growth.
7. There seems to be a stable increase in shareholders' equity, indicating a positive trend in the company's financial health.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year's quarter. The estimates range from $1.44 to $1.63, based on 25 analysts' projections.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, an increase from the previous year's EPS of $6.13. The analysts' estimates range from $6.43 to $6.92, with insights from 39 analysts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a range of estimates between $6.40 and $7.90. This forecast is based on projections from 39 analysts.
Overall, the analysts are generally optimistic about the company's future earnings per share, with expected growth in both the quarterly and annual results over the coming years.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions about the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years while still remaining positive.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of expectations for the future price of the security, with the average and median both indicating a potential increase from the current price. The low and high ends of the forecast suggest a wide range of possible outcomes, highlighting the uncertainty in predicting future security prices.MACD of JSPR